120
Participants
Start Date
June 21, 2017
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
Micafungin
Intravenous
Site HK203, New Territories
Site HK202, Pok Fu Lam
Site SG801, Singapore
Site KR401, Seoul
Site KR402, Seoul
Site KR403, Seoul
Site KR404, Seoul
Site TW606, Changhua
Site TW603, Taichung
Site TW605, Taichung
Site TW601, Taipei
Site TW604, Taipei
Site TW602, Taoyuan District
Site TH701, Bangkok
Site TH703, Bangkok
Site TH704, Chiang Mai
Astellas Pharma Singapore Pte. Ltd.
INDUSTRY